Physician

Dimitrios Barmpouletos, M.D.

According to 2025 Medicare claims, Dimitrios Barmpouletos, M.D. (NPI: 1629260013) practices cardiology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (NPI: 1124122387; TIN: 232865181) and primary practice location at 08360-5843. Barmpouletos is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Barmpouletos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,100 traditional Medicare patients, billed 4,093 HCPCS/CPT codes, and received $234,300 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 2,937 prescription claims across 441 beneficiaries totaling $544,647 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 11 claims. Open Payments data shows 5 records totaling $111. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $403,787 to $234,300. In contrast, Part D prescription costs have moved sharply higher in recent years, from $144,220 to $544,647. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,592	5,647	$403,787
2016	1,763	6,417	$421,841
2017	1,706	6,618	$405,012
2018	1,952	7,226	$460,332
2019	1,751	4,199	$261,171
2020	1,321	3,047	$198,420
2021	1,224	3,102	$217,841
2022	988	3,632	$275,316
2023	1,066	3,696	$230,661
2024	1,100	4,093	$234,300

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	268	1,596	$144,220
2016	343	2,454	$228,711
2017	441	3,550	$330,087
2018	510	4,287	$458,388
2019	507	3,821	$474,799
2020	355	1,548	$179,571
2021	218	1,061	$138,669
2022	287	1,531	$229,819
2023	360	2,313	$416,594
2024	441	2,937	$544,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$20,818
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	290	302	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	324	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	271	442	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	324	587	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	637	798	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	194	13,044	$245,301
Entresto	Sacubitril/Valsartan	42	3,532	$74,720
Farxiga	Dapagliflozin Propanediol	55	3,375	$61,930
Xarelto	Rivaroxaban	52	2,640	$48,261
Repatha Sureclick	Evolocumab	43	1,714	$32,771

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$111	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dimitrios Barmpouletos, M.D.?

Tedicare shows public-source Medicare data for Dimitrios Barmpouletos, M.D. (NPI 1629260013), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dimitrios Barmpouletos, M.D. have ACO affiliation data?

Dimitrios Barmpouletos, M.D. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Dimitrios Barmpouletos, M.D.?

Dimitrios Barmpouletos, M.D. is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (billing NPI 1124122387) in the available physician profile data.

Does Dimitrios Barmpouletos, M.D. have Open Payments data?

Dimitrios Barmpouletos, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.